Back
Becton, Dickinson and Company (BDX)
Health CareBDX · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$151.92
+0.71%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$5.82
ROE
6.7%
Gross margin
47.1%
Debt/Equity
0.72x
Revenue growth
5.2%
Becton, Dickinson and Company — company intelligence
Earnings surprises
Q2 2026$2.90 vs $2.80 est+3.5%
Q1 2026$2.91 vs $2.84 est+2.4%
Q4 2025$3.96 vs $3.96 est-0.0%
Q3 2025$3.68 vs $3.44 est+7.1%
Insider activity · 90 days
5 buys8 sellsnet +6,068 shares
Muhsin BilalSell 1,935 · Jul 2, 2026
Muhsin BilalBuy 14,342 · Jul 1, 2026
Feld MichaelSell 75 · Jun 26, 2026
Recent SEC filings
4 — Insider transaction reportJul 6, 2026
4 — Insider transaction reportJun 26, 2026
4 — Insider transaction reportJun 25, 2026
Latest news
Evercore ISI Group Maintains Outperform on Becton Dickinson, Lowers Price Target to $180 — Benzinga · 4d ago
Becton, Dickinson and Company: Now Is A Great Time To Buy — SeekingAlpha · 1w ago
Becton, Dickinson - Stable Undervaluation In 1Q26, Upside Is There — SeekingAlpha · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Becton, Dickinson and Company
Weekly undervalued picks (like BDX)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.